{"nct_id":"NCT03717155","title":"Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC","status":"COMPLETED","status_verified_date":"2022-04","start_date":"2018-10-30","start_date_type":"ACTUAL","primary_completion_date":"2020-09-30","primary_completion_date_type":"ACTUAL","completion_date":"2021-05-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}